Amgen | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 350.71B 19.93B 2025-05
Agios Pharmaceuticals USD 1.72B 21M 2025-05
ALKERMES USD 5.14B 301M 2025-05
Amgen USD 150.93B 16.57B 2025-05
Biogen USD 17.99B 2.04B 2025-05
BioMarin Pharmaceutical USD 11.82B 1.73B 2025-05
Bristol-Myers Squibb USD 101.53B 22.57B 2025-05
Eli Lilly USD 783.46B 41.8B 2025-05
Genmab DKK 98.78B 8.42B 2024-12
Gilead Sciences USD 128.54B 11.15B 2025-05
GlaxoSmithKline GBP 60.04B 311.52M 2025-05
Glaxosmithkline USD 69.83B 14.22B 2024-12
Incyte USD 14.08B 2.36B 2025-05
Ionis Pharmaceuticals USD 4.78B 14M 2025-05
J&J USD 374.87B 24.78B 2025-05
Merck USD 212.34B 13.54B 2025-05
Moderna USD 10.66B 297M 2025-05
Neurocrine Biosciences USD 10.91B 2.91B 2025-05
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 135.96B 7.76B 2025-05
PTC Therapeutics USD 3.51B 653M 2024-12
Regeneron Pharmaceuticals USD 66.6B 2.74B 2025-05
Sanofi EUR 122.48B 3.37B 2025-05
Sarepta Therapeutics USD 11.78B 128M 2024-12
Takeda JPY 6.61T 16.72B 2024-12
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 130.09B 26.64B 2025-05



Amgen Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.